Univariate | Multivariable | |||
---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | |
Prone | ||||
Early = no | Reference | Reference | ||
Early = yes | 0.86 (0.69—1.08) | 0.2035 | 0.92 (0.71—1.19) | 0.5206 |
Sex | ||||
Women | Reference | Reference | ||
Men | 1.33 (1.05—1.68) | 0.0183 | 1.28 (0.99—1.67) | 0.0645 |
Age, per year | 1.07 (1.06—1.09) | < 0.001 | 1.07 (1.06—1.09) | < 0.001 |
Comorbidity | ||||
Cardiac disease | 1.93 (1.46—2.56) | < 0.001 | 1.14 (0.83—1.57) | 0.4203 |
COPD/Asthma | 1.08 (0.81—1.43) | 0.5844 | 1.15 (0.84—1.56) | 0.3846 |
Diabetes | 1.22 (0.97—1.54) | 0.0807 | 1.12 (0.86—1.45) | 0.4021 |
Obesitya | 0.63 (0.43—0.89) | 0.0122 | 1.15 (0.76—1.72) | 0.4979 |
Hypertension | 1.33 (1.08—1.64) | 0.0071 | 0.86 (0.67—1.10) | 0.2276 |
Immune deficiency | 1.52 (1.04—2.19) | 0.0271 | 1.60 (1.05—2.42) | 0.0279 |
Chronic liver disease | 0.81 (0.18—2.72) | 0.7502 | 0.57 (0.11—2.33) | 0.4637 |
Chronic kidney disease | 1.61 (1.05—2.44) | 0.0268 | 1.05 (0.65—1.66) | 0.8535 |
Neuromuscular disease | 0.69 (0.20—1.94) | 0.5167 | 0.62 (0.17—1.92) | 0.4384 |
Malignancyb | 3.02 (1.48—6.26) | 0.0025 | 2.12 (0.97—4.69) | 0.0585 |
PaO2/FiO2 ratio, per 1 kPa increase | 0.97 (0.94—1) | 0.0370 | 0.98 (0.95 – 1.02) | 0.3362 |
SAPS3c, per 1 unit increase | 1.05 (1.04—1.07) | < 0.001 | 1.05 (1.04—1.07) | < 0.001 |
Admission months | ||||
March – April 2020 | Reference | Reference | ||
May – August 2020 | 0.57 (0.39—0.83) | 0.0037 | 0.45 (0.30—0.68 | < 0.001 |
September – December 2020 | 1.19 (0.88—1.60) | 0.2489 | 0.80 (0.57—1.11) | 0.1848 |
January – April 2021 | 0.91 (0.71—1.18) | 0.4793 | 0.62 (0.46—0.83) | 0.0014 |